MX350871B - Vehiculo masticable para absorcion bucal. - Google Patents

Vehiculo masticable para absorcion bucal.

Info

Publication number
MX350871B
MX350871B MX2013009773A MX2013009773A MX350871B MX 350871 B MX350871 B MX 350871B MX 2013009773 A MX2013009773 A MX 2013009773A MX 2013009773 A MX2013009773 A MX 2013009773A MX 350871 B MX350871 B MX 350871B
Authority
MX
Mexico
Prior art keywords
dosage form
buccal delivery
delivery dosage
mouth
active ingredients
Prior art date
Application number
MX2013009773A
Other languages
English (en)
Other versions
MX2013009773A (es
Inventor
Purcell Marc
Original Assignee
Tech Khloros Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tech Khloros Inc filed Critical Tech Khloros Inc
Publication of MX2013009773A publication Critical patent/MX2013009773A/es
Publication of MX350871B publication Critical patent/MX350871B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)

Abstract

La presente invención describe una forma de dosis masticable de administración bucal no efervescente para absorción en mucosa oral de un ingrediente activo en la boca de un sujeto, la cual caracterizada porque comprende: -al menos un modulador de pH para regular el pH oral durante la masticación en donde el por lo menos un modulador de pH es CO2 atrapado; y -una cantidad terapéuticamente efectiva de al menos un ingrediente activo que es una sustancia farmacéutica o biológicamente activa; en donde el ingrediente activo se dispersa en la boca del sujeto por masticación.
MX2013009773A 2011-02-28 2012-02-28 Vehiculo masticable para absorcion bucal. MX350871B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161447259P 2011-02-28 2011-02-28
US201261591572P 2012-01-27 2012-01-27
PCT/CA2012/050117 WO2012116445A1 (en) 2011-02-28 2012-02-28 Chewable vehicle for mouth absorption

Publications (2)

Publication Number Publication Date
MX2013009773A MX2013009773A (es) 2014-03-27
MX350871B true MX350871B (es) 2017-09-19

Family

ID=46757324

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009773A MX350871B (es) 2011-02-28 2012-02-28 Vehiculo masticable para absorcion bucal.

Country Status (9)

Country Link
US (2) US10111831B2 (es)
EP (1) EP2680828A4 (es)
JP (1) JP2014506894A (es)
CN (1) CN103491951A (es)
AU (1) AU2012222825B2 (es)
BR (1) BR112013022044A2 (es)
CA (1) CA2827242C (es)
MX (1) MX350871B (es)
WO (1) WO2012116445A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITAN20120101A1 (it) * 2012-08-06 2014-02-07 Fitolux Pro S R L Composizione a uso topico, a base di colostro di capra.
ITAN20120100A1 (it) * 2012-08-06 2014-02-07 Fitolux Pro S R L Integratore alimentare a base di colostro di capra.
WO2014165741A2 (en) * 2013-04-05 2014-10-09 Miller Leonard B Methods and articles of manufacture for the treatment of skin
FR3022140B1 (fr) * 2014-06-13 2016-06-03 Laurent Haddad Composition d'un dispositif medical ou produit cosmetique a base d'extrait de pepin de pamplemousse, d'extrait de feuille d'alchemille, d'extrait de stevia et de curcumine
WO2016046817A1 (en) * 2014-09-24 2016-03-31 Vital Beverages Global Inc. Compositions and methods for selective gi tract delivery
KR102597910B1 (ko) 2015-03-26 2023-11-02 재클린 엠. 이베르센 숙취상태와 연관된 증상들을 억제하기 위한 방법 및 조성물
CN104757242B (zh) * 2015-04-14 2017-06-30 陈树杰 一种治疗慢性肠胃病的保健糖果及其制备方法
WO2017035631A1 (en) * 2015-09-01 2017-03-09 Jamieson Laboratories, Ltd. Novel composition for improved sleep
KR101818211B1 (ko) 2016-04-05 2018-01-12 주식회사 엘지생활건강 우방자 추출물을 포함하는 구강질환 예방 또는 치료용 조성물
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation
DE102017107845A1 (de) * 2017-04-11 2018-10-11 Gelita Ag Gelatineprodukt mit einer Kernkomponente und Verfahren zu dessen Herstellung
US11317645B2 (en) 2018-01-29 2022-05-03 Joseph M. Fisher Compositions and methods for delaying and reducing blood alcohol concentration
CN110693885A (zh) * 2018-07-09 2020-01-17 成都百裕制药股份有限公司 预防或治疗性功能障碍的药物组合物及其用途
WO2020022923A1 (en) * 2018-07-24 2020-01-30 "Bio 8", Limited Liability Company Plant extract-based biologically active supplement having antibacterial, antiviral and antifungal action
US20200147032A1 (en) * 2018-11-14 2020-05-14 Robert K. Prud'homme Dihydromyricetin hot melt extrusion formulations and methods for forming them
JP7271158B2 (ja) * 2018-12-14 2023-05-11 株式会社ニップン Ｔｒｐａ１活性化組成物
FR3094638B1 (fr) * 2019-04-05 2023-11-24 Urgo Rech Innovation Et Developpement Produit pour la prévention et le traitement de la cinétose
US20220257689A1 (en) * 2019-07-16 2022-08-18 Advanced Female Technologies Llc Chewing gum compositions for the treatment of menstrual pain
US20210212950A1 (en) * 2020-01-15 2021-07-15 Resurgent Pharmaceuticals, Inc. Orally deliverable formulation to prevent all cause mortality and cardiovascular events
US11839622B1 (en) 2020-01-15 2023-12-12 Randall Lewarchik Consumable nutraceutical composition
CN112402424B (zh) * 2020-11-06 2022-03-29 杭州医学院 一种小分子药物及其在治疗间歇性低氧中的用途
IT202100009440A1 (it) * 2021-04-14 2022-10-14 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione orosolubile o spray per uso nel trattamento della nausea
CN113116898A (zh) * 2021-04-20 2021-07-16 北京天玺宝科技有限公司 一种具有减肥功能的包含左卡尼汀或乙酰左卡尼汀和育亨宾的组合物及其应用
WO2022245849A2 (en) * 2021-05-17 2022-11-24 Viome Life Sciences, Inc. Supplements for supporting metabolic function

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150161A (en) 1977-03-15 1979-04-17 General Foods Corporation Carbonated chewing gum
US4254149A (en) 1979-04-16 1981-03-03 General Foods Corporation Carbonated chewing gum
US4241092A (en) 1979-10-26 1980-12-23 General Foods Corporation Gasified candy dispersed in a matrix of sorbitol
US4263328A (en) 1979-10-26 1981-04-21 General Foods Corporation Tableted gasified candy
US4271206A (en) 1979-10-26 1981-06-02 General Foods Corporation Gasified candy having a predetermined shape
IT1120042B (it) 1979-11-16 1986-03-19 Buitoni Perugina Ind Ibp Prodotto dolciario
US4639368A (en) 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4933188B1 (en) * 1987-12-31 1997-07-15 Warner Lambert Co Chewing gum composition with improved physical stability
ES2010460A6 (es) 1989-03-20 1989-11-01 Escola Gallart Ramon Caramelo relleno de caramelo gasificado y procedimiento para la obtencion del mismo.
US6242019B1 (en) 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
US7244454B1 (en) 1997-12-03 2007-07-17 Wm. Wrigley Jr. Company Chewing gum product including encapsulated aspartame and sodium bicarbonate and process of preparing
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6235318B1 (en) 1999-01-21 2001-05-22 Charles M. Lombardy, Jr. Effervescent chewing gum
GB0102691D0 (en) 2001-02-02 2001-03-21 Nestle Sa Water soluable powders and tablets
US20030166535A1 (en) 2001-04-24 2003-09-04 Podolsky Daniel K. Methods and compositions for treating oral and esophageal lesions
US20020192329A1 (en) * 2001-06-05 2002-12-19 Corriveau Christine L. Confectionery product with pockets of trapped gas
US6602518B2 (en) 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
US6613346B2 (en) 2001-06-28 2003-09-02 Wm. Wrigley, Jr. Company Chewable product including active ingredient
ITMI20012481A1 (it) 2001-11-23 2003-05-23 Univ Parma Sistemi modulari per il rilascio controllato di sostanza a controllo spaziale e temporale
JP2004519467A (ja) 2002-01-25 2004-07-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 水溶性粉末および錠剤
US20030235613A1 (en) 2002-06-19 2003-12-25 Cts Chemical Industries Ltd. Popping oral administration form
KR100543750B1 (ko) 2003-05-30 2006-01-23 삼성제약공업주식회사 신규 탄산 캔디형 약제학적 제형
CA2576375C (en) 2004-08-11 2010-12-21 Cadbury Adams Usa Llc Sensate compositions and delivery systems therefor
US20060263475A1 (en) 2004-08-25 2006-11-23 Cadbury Adams Usa, Llc. Center-filled chewing gum composition
US20060280834A1 (en) 2004-08-25 2006-12-14 Cadbury Adams Usa, Llc. Center-filled chewing gum composition
US20080063747A1 (en) 2004-08-25 2008-03-13 Cadbury Adams Usa Llc Dusting compositions for chewing gum products
US20060286201A1 (en) 2004-08-25 2006-12-21 Cadbury Adams Usa Llc. Multi-modality functional ingredients in chewing gum compositions
WO2006044595A2 (en) 2004-10-13 2006-04-27 Cadbury Adams Usa Llc Effervescent pressed gum tablet compositions
DK1817014T3 (da) 2004-11-30 2012-11-19 Fertin Pharma As Fremgangsmåde til ydelse af hurtig afhjælpning til en bruger af et nikotintyggegummi
US20060211721A1 (en) * 2005-03-21 2006-09-21 Roberts Alan R Nutraceutical formulation of a cognitive enhancement system
ES2627573T3 (es) 2005-05-23 2017-07-28 Intercontinental Great Brands Llc Composición de confitería que incluye un componente elastomérico, un componente sacárido cocido y un ingrediente funcional
US20090150231A1 (en) 2005-05-23 2009-06-11 Cadbury Adams Usa Llc Package assembly for multi-modality functional ingredients in chewing gum compositions
JP5529529B2 (ja) 2006-04-05 2014-06-25 インターコンチネンタル グレート ブランズ エルエルシー 口腔輸送システムに用いるリン酸カルシウム錯体及び塩
MX2008012522A (es) 2006-04-05 2008-10-10 Cadbury Adams Usa Llc Complejo de fosfato de calcio en confiterias que contienen acido.
BRPI0709875A2 (pt) 2006-04-05 2011-07-26 Cadbury Adams Usa Llc impacto de complexo de fosfato de cÁlcio em cÁries dentais
FR2902657B1 (fr) 2006-06-21 2009-01-16 Virbac Sa Sa Granules ou granules effervescents
CA2670694A1 (en) 2006-11-27 2008-11-20 National Research Council Of Canada Soft gel formulations
WO2008122286A1 (en) 2007-04-04 2008-10-16 Gumlink A/S Center-filled chewing gum product for dental care
EP2162013B1 (en) 2007-07-06 2016-04-06 Gumlink A/S Compressed chewing gum comprising an encapsulation delivery system comprising natural resin
WO2009006898A1 (en) * 2007-07-11 2009-01-15 Fertin Pharma A/S Stable medicated chewing gum comprising cyclodextrin inclusion complex
JP4945368B2 (ja) * 2007-08-10 2012-06-06 本田技研工業株式会社 能動型防振支持装置及びその制御方法
US20090081291A1 (en) 2007-09-26 2009-03-26 Gin Jerry B Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User
WO2009041714A1 (ja) 2007-09-26 2009-04-02 Mikasa Seiyaku Co., Ltd. フリーラジカル性疾患用外用剤
PT2203181T (pt) 2007-10-16 2018-05-10 Biocon Ltd Uma composição farmacêutica sólida para administração por via oral e o seu processo de fabrico
US20090142443A1 (en) 2007-11-29 2009-06-04 Cadbury Adams Usa Llc Multi-region chewing gum with actives
US20090155392A1 (en) * 2007-12-17 2009-06-18 Bret David Nelson Methods and Systems for Sublingual Guarana Administration
EP2229156B1 (en) * 2007-12-20 2016-11-09 Fertin Pharma A/S Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet
JP4964793B2 (ja) 2008-01-22 2012-07-04 アサヒ飲料株式会社 シトルリン含有飲食品及びその製造方法
WO2009108769A2 (en) 2008-02-27 2009-09-03 Cadbury Adams Usa, Llc Multi-region confectionery
FR2932385B1 (fr) 2008-06-17 2013-03-08 David Marcel Dohan Composition constituee d'extraits naturels microencapsules pour application buccale, cutanee ou muqueuse
KR101775169B1 (ko) 2009-04-24 2017-09-05 옴야 인터내셔널 아게 활성 성분의 방출 조절을 위한 미립자 조성물
CN101966165B (zh) 2009-07-14 2012-06-13 无锡健而乐医药科技有限公司 口腔吸收固体泡腾制剂
US20110086085A1 (en) 2009-10-13 2011-04-14 Wenzel Scott W Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
US20110305738A1 (en) 2010-06-09 2011-12-15 Ladizinsky Daniel A Oxygenating Oral Compositions
WO2012106582A2 (en) 2011-02-03 2012-08-09 Snap Infusion Llc Confection composition

Also Published As

Publication number Publication date
AU2012222825A1 (en) 2013-05-02
US20130337096A1 (en) 2013-12-19
EP2680828A1 (en) 2014-01-08
WO2012116445A1 (en) 2012-09-07
CN103491951A (zh) 2014-01-01
AU2012222825B2 (en) 2016-01-21
BR112013022044A2 (pt) 2016-11-29
JP2014506894A (ja) 2014-03-20
EP2680828A4 (en) 2014-07-30
US20190015324A1 (en) 2019-01-17
CA2827242A1 (en) 2012-09-07
MX2013009773A (es) 2014-03-27
CA2827242C (en) 2015-06-30
US10111831B2 (en) 2018-10-30

Similar Documents

Publication Publication Date Title
MX2013009773A (es) Vehiculo masticable para absorcion bucal.
WO2008011194A3 (en) Transmucosal delivery devices with enhanced uptake
DE602007007991D1 (de) Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung
EP2248519A3 (en) Non-mucoadhesive film dosage forms
WO2010062688A3 (en) Dosage form for insertion into the mouth
WO2009088414A3 (en) Oral pharmaceutical dosage forms
MA34832B1 (fr) Compositions biodegradables d'administration de medicaments
EP4233978A3 (en) Oral delivery of active drug substances
GB2501219A (en) Orally bioavailable peptide drug compositions and methods thereof
MX354416B (es) Formulaciones a base de nalbufina y sus usos.
MX347101B (es) Forma de dosis de disolucion rapida de vacuna oral que usa almidon.
IL195931A0 (en) Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
EA201591188A1 (ru) Доставка глатирамера ацетата через слизистую оболочку
WO2010098627A2 (ko) 약제학적 제제
BR112013011942A2 (pt) formulação, forma de dosagem de droga para administração transmucosa oral, sistema transmucoso de fornecimento de droga, método de tratamento e profilaxia de uma doença ou distúrbio, método de tratamento, formulação, método para tratamento ou prevenção de carcinoma de célula escamosa de cabeça e pescoço (hnscc), método para quimioprevenção de um câncer oral ou condição pré-cancerosa, método para aumentar a concentração de uma composição de retinida, método de tratamento e profilaxia de uma doença ou condição, método de ratamento de um sujeito apresentando uma condição médica sintomática, método de tratamento de um câncer oral ou condição pré-cancerosa num paciente, método para fazer um sistema de fornecimento de droga bucal, método para aumentar a liberação e permeação de uma composição de retinida.
WO2012085249A3 (en) Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
WO2010003472A3 (de) Lutschzusammensetzung zur behandlung von entzündlichen erkrankungen des mund- und rachenraums
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
JO3239B1 (ar) تركيبات جالينية من مركبات عضوية
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
TN2015000156A1 (en) Dispersible tablet
WO2011161223A3 (en) Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
WO2011156822A3 (en) Pharmaceutical compositions
WO2011153819A8 (zh) 用于戒毒的药物组合物

Legal Events

Date Code Title Description
FG Grant or registration